[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[2]
|
Li, L., Jiang, M., Li, T., et al. (2022) Absolute Risk and Attributable Frac-tion of Type-Specific Human Papillomavirus in Cervical Cancer and Precancerous Lesions—A Population-Based Study of 6286 Women in Rural Areas of China. Journal of Clinical Medicine, 11, 6483. https://doi.org/10.3390/jcm11216483
|
[3]
|
Madsen, P., Rasmussen, H.H., Leffers, H., et al. (1991) Molecular Cloning, Occurrence, and Expression of a Novel Partially Secreted Protein “Psoriasin” That Is Highly Up-Regulated in Psoriatic Skin. Journal of Investigative Dermatology, 97, 701-712. https://doi.org/10.1111/1523-1747.ep12484041
|
[4]
|
Chen, H., Xu, C., Jin, Q. and Liu, Z. (2014) S100 Protein Family in Human Cancer. American Journal of Cancer Research, 4, 89-115.
|
[5]
|
Emberley, E.D., Murphy, L.C. and Watson, P.H. (2004) S100A7 and the Progression of Breast Cancer. Breast Cancer Research, 6, 153-159. https://doi.org/10.1186/bcr816
|
[6]
|
Kesting, M.R., Sudhoff, H., Hasler, R.J., et al. (2009) Psoriasin (S100A7) Up-Regulation in Oral Squamous Cell Carcinoma and Its Relation to Clinicopathologic Features. Oral Oncology, 45, 731-736.
https://doi.org/10.1016/j.oraloncology.2008.11.012
|
[7]
|
Lu, Z., Zheng, S., Liu, C., et al. (2021) S100A7 as a Po-tential Diagnostic and Prognostic Biomarker of Esophageal Squamous Cell Carcinoma Promotes M2 Macrophage Infil-tration and Angiogenesis. Clinical and Translational Medicine, 11, e459. https://doi.org/10.1002/ctm2.459
|
[8]
|
Wang, R., Li, Y., Hu, E., et al. (2017) S100A7 Promotes Lung Adenocarci-noma to Squamous Carcinoma Transdifferentiation, and Its Expression Is Differentially Regulated by the Hippo-YAP Pathway in Lung Cancer Cells. Oncotarget, 8, 24804-24814. https://doi.org/10.18632/oncotarget.15063
|
[9]
|
Alowami, S., Qing, G., Emberley, E., et al. (2003) Psoriasin (S100A7) Expression Is Altered during Skin Tumorigenesis. BMC Dermatology, 3, Article No. 1. https://doi.org/10.1186/1471-5945-3-1
|
[10]
|
Leygue, E., Snell, L., Hiller, T., et al. (1996) Differential Expression of Psoriasin Messenger RNA between in Situ and Invasive Human Breast Carcinoma. Cancer Research, 56, 4606-4609.
|
[11]
|
Qu, Y., Liu, H. and Li, S. (2014) Effects of S100A7 on the Proliferation and Invasiveness of Esopha-geal Squamous Cell Carcinoma EC9706 Cells and Possible Mechanisms. Chinese Medical Journal, 94, 144-147.
|
[12]
|
Zhang, H., Wang, Y., Chen, Y., et al. (2007) Identification and Validation of S100A7 Associated with Lung Squamous Cell Carcinoma Metastasis to Brain. Lung Cancer, 57, 37-45. https://doi.org/10.1016/j.lungcan.2007.02.020
|
[13]
|
Tian, T., Li, X., Hua, Z., et al. (2017) S100A7 Promotes the Migration, Invasion and Metastasis of Human Cervical Cancer Cells through Epithelial-Mesenchymal Transition. Onco-target, 8, 24964-24977.
https://doi.org/10.18632/oncotarget.15329
|
[14]
|
Dey, K.K., Sarkar, S., Pal, I., et al. (2015) Mechanistic Attributes of S100A7 (Psoriasin) in Resistance of Anoikis Resulting Tumor Progression in Squamous Cell Carcinoma of the Oral Cavity. Cancer Cell International, 15, 74.
https://doi.org/10.1186/s12935-015-0226-9
|
[15]
|
Liu, G., Wu, Q., Liu, G., et al. (2015) Psoriasin (S100A7) Is a Novel Biomarker for Lung Squamous Cell Carcinoma in Humans. Cancer Cell International, 15, 18. https://doi.org/10.1186/s12935-014-0154-0
|